Hepion Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Hepion Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2013 to Q3 2024.
  • Hepion Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $28.6K, a 91% decline year-over-year.
  • Hepion Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $913K, a 63.4% decline year-over-year.
  • Hepion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.42M, a 5.32% decline from 2022.
  • Hepion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.55M, a 45.3% decline from 2021.
  • Hepion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.67M, a 96.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $913K $28.6K -$290K -91% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.2M $28.6K +$11.7K +69.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.19M $706K -$1.22M -63.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-21
Q4 2023 $2.42M $150K -$81.6K -35.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $2.5M $319K -$298K -48.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $2.8M $16.9K -$146K -89.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $2.94M $1.93M +$389K +25.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-21
Q4 2022 $2.55M $232K -$616K -72.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $3.17M $617K -$852K -58% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $4.02M $163K -$1.23M -88.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $5.25M $1.54M +$584K +60.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $4.67M $848K Oct 1, 2021 Dec 31, 2021 10-K 2023-04-10
Q3 2021 $1.47M +$478K +48.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.39M +$1M +253% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $958K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $991K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $395K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q3 2018 $62.9K -$328K -83.9% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $153K -$120K -44.1% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $217K -$337K -60.8% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-15
Q3 2017 $391K -$110K -21.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $273K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $554K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 $501K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2015 $2.12M $929K +$878K +1717% Apr 1, 2015 Jun 30, 2015 10-K 2015-09-25
Q1 2015 $1.24M $678K +$535K +373% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-14
Q4 2014 $705K $399K +$398K +46738% Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-12
Q3 2014 $307K $112K +$112K Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $195K $51.2K +$51.2K Apr 1, 2014 Jun 30, 2014 10-K 2015-09-25
Q1 2014 $144K $143K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $852 Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-12
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $0 May 15, 2013 Jun 30, 2013 10-K 2014-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.